Tiagabine treatment and DNA damage in rat astrocytes: an in vitro study by comet assay

Neurosci Lett. 2001 Jun 22;306(1-2):17-20. doi: 10.1016/s0304-3940(01)01836-5.

Abstract

We studied in vitro the effects of Tiagabine on genomic DNA of cortical rat astrocytes. To evaluate DNA damage, we used a relatively simple technique called Single Cell Gel Electrophoresis or Comet assay. Tiagabine was dissolved in culture medium and added at concentration of 1, 10, 20 and 50 microg/ml on 12-day old cultured astrocytes. In presence of 1 and 10 microg/ml of Tiagabine, no DNA damage was observed after 48 h of treatment. A moderate DNA damage was instead observed for cells exposed to 20 microg/ml of antiepileptic drug. Finally, DNA fragmentation was more evident after treatment with 50 microg/ml of Tiagabine. We conclude that Tiagabine, at the usual recommended doses, does not appear to influence negatively the cortical rat astrocytes, inducing DNA fragmentation only at very high concentrations.

MeSH terms

  • Animals
  • Animals, Newborn
  • Astrocytes / drug effects*
  • Astrocytes / metabolism
  • Astrocytes / pathology
  • Cells, Cultured / drug effects*
  • Cells, Cultured / metabolism
  • Cells, Cultured / pathology
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / physiopathology
  • Comet Assay / methods
  • DNA Damage / drug effects*
  • DNA Damage / physiology
  • Dose-Response Relationship, Drug
  • Epilepsy / drug therapy*
  • GABA Agonists / toxicity*
  • Genome
  • Glial Fibrillary Acidic Protein / metabolism
  • Nerve Degeneration / chemically induced
  • Nerve Degeneration / metabolism
  • Nerve Degeneration / physiopathology
  • Nipecotic Acids / toxicity*
  • Rats
  • Tiagabine

Substances

  • GABA Agonists
  • Glial Fibrillary Acidic Protein
  • Nipecotic Acids
  • Tiagabine